SK Bioscience chief says "national pride" prevents China from accepting foreign COVID vaccines- FT
Jan 8 (Reuters) - SK Bioscience Co Ltd 302440.KS chief
executive Jaeyong Ahn said in a Financial Times interview that
it is unlikely that the vaccine maker can supply COVID-19
vaccines to China amid its recent outbreak due to Beijing's
"national pride".
Ahn said that it was "unrealistic" to supply COVID vaccines
to China, as the country insists on using its domestic vaccines,
the newspaper quoted him as saying.
(Reporting by Rishabh Jaiswal in Bengaluru)
((rishabh.jaiswal@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine